Researchers develop dementia risk score for patients with type 2 diabetes

08/19/2013 | MedPage Today (free registration)

Kaiser Permanente researchers have developed a new risk score that can be used by clinicians to determine patients with type 2 diabetes who are at risk for having dementia, according to a study in The Lancet Diabetes & Endocrinology. Researchers determined the score by examining information from two longitudinal cohorts of patients age 60 and older who had 10 or more years of follow-up recorded in the Kaiser Permanente Northern California Diabetes Registry. The risk score is based on factors such as age, education, diabetic foot disease, acute metabolic events, and cerebrovascular and cardiovascular disease.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park